mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.0001 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.22 |
0.0002 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.0003 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |